Clinical Trial Update: Withdrawal of Dupilumab in Severe Asthma [Phase 4]

View source ↗

Summary

The Phase 4 trial of dupilumab for severe asthma is being withdrawn and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Severe Asthma | Phase 4 | Status: NOT_YET_RECRUITING